Re-evaluating the approach to drug target discovery in multidrug-resistant Gram-negative bacilli

Future Microbiol. 2014;9(10):1113-6. doi: 10.2217/fmb.14.72.

Authors

Timothy C Umland¹, L Wayne Schultz, Thomas A Russo

Affiliation

¹ Hauptman-Woodward Medical Research Institute, 700 Ellicott St., Buffalo, NY 14203, USA.

PMID: 25405880
DOI: 10.2217/fmb.14.72

No abstract available

Keywords: Acinetobacter baumannii; Gram-negative bacilli; antibiotic target; bacterial drug target; essential genes; multidrug resistant.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Anti-Infective Agents / isolation & purification*
Anti-Infective Agents / pharmacology*
Drug Discovery / methods*
Drug Discovery / trends
Drug Resistance, Multiple, Bacterial*
Genes, Bacterial
Genes, Essential
Gram-Negative Bacteria / drug effects*

Substances

Anti-Infective Agents